BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18924086)

  • 1. Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population.
    Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D
    Int J Artif Organs; 2008 Sep; 31(9):752-60. PubMed ID: 18924086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis.
    Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D
    Med Microbiol Immunol; 2002 Oct; 191(2):107-14. PubMed ID: 12410350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones.
    Yamada M; Yoshida J; Hatou S; Yoshida T; Minagawa Y
    Br J Ophthalmol; 2008 Jun; 92(6):848-51. PubMed ID: 18460536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
    Nagai K; Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2001 Sep; 48(3):365-74. PubMed ID: 11533001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.
    Betanzos-Cabrera G; Juárez-Verdayes MA; González-González G; Cancino-Díaz ME; Cancino-Díaz JC
    Ophthalmic Res; 2009; 42(1):43-8. PubMed ID: 19478540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin and biofilm production by coagulase-negative staphylococci.
    Pérez-Giraldo C; Gonzalez-Velasco C; Sánchez-Silos RM; Hurtado C; Blanco MT; Gómez-García AC
    Chemotherapy; 2004 Jun; 50(2):101-4. PubMed ID: 15211086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zirconium Nitride Coating Reduced Staphylococcus epidermidis Biofilm Formation on Orthopaedic Implant Surfaces: An In Vitro Study.
    Pilz M; Staats K; Tobudic S; Assadian O; Presterl E; Windhager R; Holinka J
    Clin Orthop Relat Res; 2019 Feb; 477(2):461-466. PubMed ID: 30418277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
    Yassien M; Khardori N
    Diagn Microbiol Infect Dis; 2001 Jul; 40(3):79-89. PubMed ID: 11502373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
    Reddy AK; Garg P; Alam MR; Gopinathan U; Sharma S; Krishnaiah S
    Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.
    Heinemann B; Wisplinghoff H; Edmond M; Seifert H
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2211-3. PubMed ID: 10898706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of the new quinolone WCK 771 against staphylococci.
    Jacobs MR; Bajaksouzian S; Windau A; Appelbaum PC; Patel MV; Gupte SV; Bhagwat SS; De Souza NJ; Khorakiwala HF
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3338-42. PubMed ID: 15328094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
    Naber KG; Hollauer K; Kirchbauer D; Witte W
    Int J Antimicrob Agents; 2000 Nov; 16(3):239-43. PubMed ID: 11091042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
    Hardy D; Amsterdam D; Mandell LA; Rotstein C
    Antimicrob Agents Chemother; 2000 Mar; 44(3):802-5. PubMed ID: 10681365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
    Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
    APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.
    Sierra JM; Cabeza JG; Ruiz Chaler M; Montero T; Hernandez J; Mensa J; Llagostera M; Vila J
    Clin Microbiol Infect; 2005 Sep; 11(9):750-8. PubMed ID: 16104991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
    Pereyre S; Renaudin H; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3165-8. PubMed ID: 15273141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
    Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology.
    Hellmark B; Söderquist B; Unemo M; Nilsdotter-Augustinsson Å
    Int J Med Microbiol; 2013 Jan; 303(1):32-9. PubMed ID: 23245829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.